| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L Køber, ... New England Journal of Medicine 349 (20), 1893-1906, 2003 | 3322 | 2003 |
| Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation A Investigators New England Journal Medicine 2009 360, 2066-78, 0 | 3319* | |
| Chagas disease A Rassi, JA Marin-Neto The Lancet 375 (9723), 1388-1402, 2010 | 3095 | 2010 |
| Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy CA Morillo, JA Marin-Neto, A Avezum, S Sosa-Estani, A Rassi Jr, F Rosas, ... New England Journal of Medicine 373 (14), 1295-1306, 2015 | 1093 | 2015 |
| Evaluation and treatment of Chagas disease in the United States: a systematic review C Bern, SP Montgomery, BL Herwaldt, A Rassi, JA Marin-Neto, ... Jama 298 (18), 2171-2181, 2007 | 974 | 2007 |
| Development and validation of a risk score for predicting death in Chagas' heart disease A Rassi Jr, A Rassi, WC Little, SS Xavier, SG Rassi, AG Rassi, GG Rassi, ... New England Journal of Medicine 355 (8), 799-808, 2006 | 805 | 2006 |
| American trypanosomiasis (Chagas disease) A Rassi, JM de Rezende Infectious Disease Clinics 26 (2), 275-291, 2012 | 769 | 2012 |
| Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. OT Investigators. JAMA 310 (23), 2510-22, 2013 | 760 | 2013 |
| Predictors of mortality in chronic Chagas disease: a systematic review of observational studies A Rassi Jr, A Rassi, SG Rassi Circulation 115 (9), 1101-1108, 2007 | 450 | 2007 |
| Chagas' heart disease AR Jr, A Rassi, WC Little Clinical cardiology 23 (12), 883-889, 2000 | 447 | 2000 |
| II Consenso Brasileiro em doença de Chagas, 2015 JCP Dias, AN Ramos Jr, ED Gontijo, A Luquetti, MA Shikanai-Yasuda, ... Epidemiologia e Serviços de Saúde 25, 7-86, 2016 | 426 | 2016 |
| Sudden death in Chagas' disease A Rassi Jr, SG Rassi, A Rassi Arquivos brasileiros de cardiologia 76 (1), 86-96, 2001 | 344 | 2001 |
| 2 nd Brazilian Consensus on Chagas Disease, 2015 JCP Dias, AN Ramos Jr, ED Gontijo, A Luquetti, MA Shikanai-Yasuda, ... Revista da Sociedade Brasileira de Medicina Tropical 49, 03-60, 2016 | 317 | 2016 |
| Irbesartan in patients with atrial fibrillation Active I Investigators New England Journal of Medicine 364 (10), 928-938, 2011 | 294 | 2011 |
| Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification A Rassi Jr, A Rassi, JA Marin-Neto Memorias do Instituto Oswaldo Cruz 104, 152-158, 2009 | 256 | 2009 |
| Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For … FA de Cardiología, S Argentina, SP Preto, CA Morillo, N America American heart journal, 2008 | 250 | 2008 |
| Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease JL Affranchino, CF Ibañez, AO Luquetti, A Rassi, MB Reyes, RA Macina, ... Molecular and biochemical parasitology 34 (3), 221-228, 1989 | 236 | 1989 |
| The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease JA Marin-Neto, A Rassi Jr, A Avezum Jr, AC Mattos, A Rassi Memórias do Instituto Oswaldo Cruz 104, 319-324, 2009 | 232 | 2009 |
| Diretrizes da Sociedade Brasileira de Cardiologia: intevenção coronária percutânea e métodos adjuntos diagnósticos em cardiologia intervencionista (II Edição-2008) LA Mattos, L Neto, A Rassi Junior, JA Marin-Neto, AGM Sousa, FS Devito Rev. bras. cardiol. invasiva, 9-88, 2008 | 196 | 2008 |
| Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting … A Rassi, JA Marin Memórias do Instituto Oswaldo Cruz 112, 224-235, 2017 | 194 | 2017 |
